Correction to: Real‑World Evidence of the Safety and Effectiveness of Atogepant Added to OnabotulinumtoxinA for the Preventive Treatment of Chronic Migraine: A Retrospective Chart Review
Pain Ther. 2024 Dec 24.
doi: 10.1007/s40122-024-00692-5.
Online ahead of print.